Developer docs
API playgroundTry for free, no card

Search company profiles

Foqus

Full company profile

uuid0003wdh

Namestring
Foqus
Legal namestring
Foqus Technologies Inc
Websiteurl
foqus.ca
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Foqus Technologies Inc is a Canadian medical imaging software company that develops AI-powered reconstruction software to accelerate MRI scans without requiring hardware modifications to existing 1.5T and 3T scanners. The company's core product, DeepFoqus-Accelerate, reduces MRI acquisition times by approximately 75% (4X acceleration), targeting brain MRI scan durations of under five minutes and supporting 2D and 3D T1, T2, and FLAIR sequences. The company serves hospitals, healthcare systems, and diagnostic imaging centers — segments constrained by long MRI wait times (3-4 months in Canada), patient discomfort during extended scans, and limited scanner throughput.

The technology stack combines proprietary quantum polarization algorithms that boost the physical magnetic resonance signal by nearly 150% (comparable to doubling magnetic field strength without hardware changes) with deep-learning image reconstruction that processes undersampled k-space data into diagnostic-quality output. The IP foundation includes a granted US patent (US10560096B2) covering a quantum signal booster method and pending PCT applications for quantum hyperpolarization and quantum noise suppression. DeepFoqus-Accelerate has been validated on more than 20,000 MRI images and is FDA 510(k) cleared (K241982), Health Canada licensed (113256), and ISO 13485:2016 MDSAP certified.

Foqus generates revenue through software licensing to healthcare providers and MRI service providers, using a direct enterprise sales motion with quote-based pricing. Go-to-market is being built through direct sales in Canada and the United States, a GTM partnership with Mohawk Medbuy Corporation (a national Canadian healthcare procurement organization), and accelerator support from the Boston Canadian Technology Accelerator program for US entry. The company is privately held and backed by venture capital (Quantonation, CABHI), government R&D programs (NRC IRAP, OBIO LSCTC, ISED AI Compute Access Fund, Ontario Brain Institute), and academic support (University of Waterloo). At the time of the source data, Foqus states it is beginning to generate revenue through initial collaborations without disclosing specific revenue figures.

Short descriptiontext

Foqus Technologies Inc is a Canadian medical imaging software company that develops DeepFoqus-Accelerate, an FDA-cleared AI and quantum-enhanced MRI reconstruction software that cuts scan times by ~75% for hospitals and imaging centers without requiring hardware upgrades.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
MRI reconstruction software, AI medical imaging, quantum imaging technology, accelerated MRI scanning, diagnostic imaging software
Industry3 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging Software
Social media profiles1 record
Revenue model1 record
1Software Licensing
TypeSubscription Recurring
Description

DeepFoqus-Accelerate is sold as a software solution that integrates with existing MRI scanners. The company generates revenue through software licensing to healthcare providers and MRI service providers. They mention beginning to generate revenue through initial collaborations and planning to achieve profitability.

foqus.ca
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1DeepFoqus-Accelerate
Description

AI-powered MRI reconstruction software for accelerated brain scanning that accepts up to 4x accelerated scans and reconstructs them to yield diagnostic-quality images.

foqus.ca
Core offering1 text field

Foqus Technologies develops and sells DeepFoqus-Accelerate, an AI-powered MRI reconstruction software that integrates with existing 1.5T and 3T MRI scanners without requiring hardware modifications. The software uses proprietary quantum algorithms and AI-enhanced reconstruction to accept up to 4x accelerated brain MRI scans (approximately 75% time reduction, with a target of sub-5-minute scans) while maintaining diagnostic-quality image output across 2D and 3D T1, T2, and FLAIR sequences. The product has received FDA 510(k) clearance and Health Canada Medical Device License, enabling commercial deployment to hospitals and imaging centers across North America.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 75% reduction in MRI scan time (4X acceleration)
+4 more records
Product overview1 text field

Foqus Technologies offers a single core product called DeepFoqus-Accelerate, an AI-powered MRI reconstruction software. This software integrates with existing MRI scanners (no hardware modifications required) and utilizes proprietary AI-enhanced reconstruction algorithms to reduce scan times by 75% while maintaining diagnostic image quality. The technology is backed by two key pillars: Quantum Polarization technology (quantum algorithms boosting signal by 150%) and AI-Accelerated MRI (deep learning image reconstruction). The product has received FDA 510(k) clearance and Health Canada approval, targeting the North American market with a focus on brain MRI imaging.

Product and service1 record
1DeepFoqus-Accelerate
CategoryMedical Imaging Software
Description

AI-powered MRI reconstruction software that integrates with existing 1.5T and 3T MRI scanners to accept up to 4x accelerated brain MRI scans and reconstruct diagnostic-quality images, reducing scan times by approximately 75% (with a target of under 5 minutes per scan). It supports 2D T1, 2D T2, 2D FLAIR, 3D T1, 3D T2, and 3D FLAIR sequences and is sold to hospitals, diagnostic imaging centers, and clinical research institutions.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2025-10-06
Description

Joint live webinar on October 15, 2025 showcasing AI-powered MRI innovations. Mohawk Medbuy is a national not-for-profit providing strategic sourcing and procurement solutions for hospitals and healthcare providers across Canada.

2Robarts Research Institute
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-05
Description

Completed a pilot project to validate DeepFoqus-Accelerate performance in real-world clinical settings using 3T MRI systems. The pilot validated software performance and effectiveness, strengthening credibility and driving new collaboration opportunities.

foqus.ca
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partner and supporter, with CEO/co-founder Dr. Sadegh Raeisi recognized through Waterloo's entrepreneurship programs.

4Boston Canadian Technology Accelerator (CTA)
Strategic tierCoreTypeGTM or Marketing Partner
Description

Accelerator program supporting high-potential companies in Tech and Life Sciences sectors with mentoring, local ecosystem connections, and opportunities to grow in the US market.

foqus.ca
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Quibim provides AI-based medical image analysis and quantification, with MRI-focused products for radiology and research customers; comparable AI-imaging value proposition and customer base.

TypeDirect peer
Description

SyntheticMR offers SyMRI software for quantitative MRI and faster brain scans via synthetic imaging, overlapping with Foqus's brain MRI acceleration focus and hospital radiology workflow.

TypeBroad incumbent
Description

GE HealthCare is a major MRI OEM whose AIR Recon DL product is an AI-based MRI reconstruction tool bundled with its scanners. Represents both a competing AI reconstruction solution and a potential integration channel for Foqus.

TypeDirect peer
Description

RapidAI provides AI-driven imaging analysis (mainly stroke and neurovascular), serving hospital radiology and stroke networks; comparable AI imaging workflow footprint to Foqus in neuro MRI.

TypeBroad incumbent
Description

Siemens Healthineers offers Deep Resolve, an AI-based MRI acceleration technology integrated into its MAGNETOM scanners, making it a direct competing AI reconstruction capability and a key OEM counterpart.

TypeDirect peer
Description

Subtle Medical builds AI-powered MRI and PET acceleration software (SubtleMR, SubtleGAD) that integrates with existing scanners. Direct overlap with DeepFoqus-Accelerate in AI reconstruction and hospital sales motion.

TypeDirect peer
Description

Arterys (now part of Tempus AI) provides cloud-native AI medical imaging platforms including MRI quantification and visualization, competing for AI imaging analytics budgets at the same hospital radiology departments.

TypeBroad incumbent
Description

Philips offers SmartSpeed AI MRI acceleration as part of its Ingenia and other MR platforms, providing competing vendor-bundled reconstruction and a major OEM integration target for Foqus.

TypeEmerging player
Description

Ezra offers AI-assisted full-body MRI screening with a focus on faster, more accessible scans for early cancer detection; overlaps with Foqus on the AI-driven faster-MRI thesis but targets consumers/employers.

TypeEmerging player
Description

Hyperfine develops portable, low-field MRI with AI-driven reconstruction, targeting point-of-care and lower-cost settings; adjacent technology (AI + MRI acceleration) and overlapping MRI access mission.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Foqus

Medical Imaging Softwarefoqus.ca

Foqus Technologies Inc is a Canadian medical imaging software company that develops DeepFoqus-Accelerate, an FDA-cleared AI and quantum-enhanced MRI reconstruction software that cuts scan times by ~75% for hospitals and imaging centers without requiring hardware upgrades.

What Foqus does

Foqus Technologies Inc is a Canadian medical imaging software company that develops AI-powered reconstruction software to accelerate MRI scans without requiring hardware modifications to existing 1.5T and 3T scanners. The company's core product, DeepFoqus-Accelerate, reduces MRI acquisition times by approximately 75% (4X acceleration), targeting brain MRI scan durations of under five minutes and supporting 2D and 3D T1, T2, and FLAIR sequences. The company serves hospitals, healthcare systems, and diagnostic imaging centers — segments constrained by long MRI wait times (3-4 months in Canada), patient discomfort during extended scans, and limited scanner throughput.

The technology stack combines proprietary quantum polarization algorithms that boost the physical magnetic resonance signal by nearly 150% (comparable to doubling magnetic field strength without hardware changes) with deep-learning image reconstruction that processes undersampled k-space data into diagnostic-quality output. The IP foundation includes a granted US patent (US10560096B2) covering a quantum signal booster method and pending PCT applications for quantum hyperpolarization and quantum noise suppression. DeepFoqus-Accelerate has been validated on more than 20,000 MRI images and is FDA 510(k) cleared (K241982), Health Canada licensed (113256), and ISO 13485:2016 MDSAP certified.

Foqus generates revenue through software licensing to healthcare providers and MRI service providers, using a direct enterprise sales motion with quote-based pricing. Go-to-market is being built through direct sales in Canada and the United States, a GTM partnership with Mohawk Medbuy Corporation (a national Canadian healthcare procurement organization), and accelerator support from the Boston Canadian Technology Accelerator program for US entry. The company is privately held and backed by venture capital (Quantonation, CABHI), government R&D programs (NRC IRAP, OBIO LSCTC, ISED AI Compute Access Fund, Ontario Brain Institute), and academic support (University of Waterloo). At the time of the source data, Foqus states it is beginning to generate revenue through initial collaborations without disclosing specific revenue figures.

Foqus firmographics

Firmographics
Name
Foqus
Legal name
Foqus Technologies Inc
Website
https://foqus.ca
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
Foqus Technologies Inc is a Canadian medical imaging software company that develops DeepFoqus-Accelerate, an FDA-cleared AI and quantum-enhanced MRI reconstruction software that cuts scan times by ~75% for hospitals and imaging centers without requiring hardware upgrades.
Ownership category
akta.pro rank

Foqus industry classification

Industry
Product category
Medical Imaging Software
NAICS
Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability

Keywords

  • MRI reconstruction software
  • AI medical imaging
  • Quantum imaging technology
  • Accelerated MRI scanning
  • Diagnostic imaging software

Where Foqus is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Foqus business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Software Licensing: DeepFoqus-Accelerate is sold as a software solution that integrates with existing MRI scanners. The company generates revenue through software licensing to healthcare providers and MRI service providers. They mention beginning to generate revenue through initial collaborations and planning to achieve profitability.

Distribution channels3 records

Marketing channels6 records

Foqus product offering

Product offering

Core offering

Foqus Technologies develops and sells DeepFoqus-Accelerate, an AI-powered MRI reconstruction software that integrates with existing 1.5T and 3T MRI scanners without requiring hardware modifications. The software uses proprietary quantum algorithms and AI-enhanced reconstruction to accept up to 4x accelerated brain MRI scans (approximately 75% time reduction, with a target of sub-5-minute scans) while maintaining diagnostic-quality image output across 2D and 3D T1, T2, and FLAIR sequences. The product has received FDA 510(k) clearance and Health Canada Medical Device License, enabling commercial deployment to hospitals and imaging centers across North America.

Product overview

Foqus Technologies offers a single core product called DeepFoqus-Accelerate, an AI-powered MRI reconstruction software. This software integrates with existing MRI scanners (no hardware modifications required) and utilizes proprietary AI-enhanced reconstruction algorithms to reduce scan times by 75% while maintaining diagnostic image quality. The technology is backed by two key pillars: Quantum Polarization technology (quantum algorithms boosting signal by 150%) and AI-Accelerated MRI (deep learning image reconstruction). The product has received FDA 510(k) clearance and Health Canada approval, targeting the North American market with a focus on brain MRI imaging.

Differentiator

Problem solved

Functional benefit

Brands

  • DeepFoqus-Accelerate: AI-powered MRI reconstruction software for accelerated brain scanning that accepts up to 4x accelerated scans and reconstructs them to yield diagnostic-quality images.

Products and services

  • DeepFoqus-Accelerate AI-powered MRI reconstruction software that integrates with existing 1.5T and 3T MRI scanners to accept up to 4x accelerated brain MRI scans and reconstruct diagnostic-quality images, reducing scan times by approximately 75% (with a target of under 5 minutes per scan). It supports 2D T1, 2D T2, 2D FLAIR, 3D T1, 3D T2, and 3D FLAIR sequences and is sold to hospitals, diagnostic imaging centers, and clinical research institutions.

Quantifiable outcome

  • 75% reduction in MRI scan time (4X acceleration)
  • +4 more outcomes

Companies that use Foqus

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Foqus technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Foqus partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Mohawk Medbuy CorporationcoreGTM or Marketing Partner · 6 October 2025Joint live webinar on October 15, 2025 showcasing AI-powered MRI innovations. Mohawk Medbuy is a national not-for-profit providing strategic sourcing and procurement solutions for hospitals and healthcare providers across Canada.
  • Robarts Research InstitutecoreStrategic or Co-development Partner · 5 May 2025Completed a pilot project to validate DeepFoqus-Accelerate performance in real-world clinical settings using 3T MRI systems. The pilot validated software performance and effectiveness, strengthening credibility and driving new collaboration opportunities.
  • University of WaterloominorStrategic or Co-development PartnerAcademic partner and supporter, with CEO/co-founder Dr. Sadegh Raeisi recognized through Waterloo's entrepreneurship programs.
  • Boston Canadian Technology Accelerator (CTA)coreGTM or Marketing PartnerAccelerator program supporting high-potential companies in Tech and Life Sciences sectors with mentoring, local ecosystem connections, and opportunities to grow in the US market.

Scale indicators6 records

Recent moves6 records

Expansion highlights3 records

Foqus competitors and assessment

Company assessment

Direct peers

  • Quibim: Quibim provides AI-based medical image analysis and quantification, with MRI-focused products for radiology and research customers; comparable AI-imaging value proposition and customer base.
  • SyntheticMR: SyntheticMR offers SyMRI software for quantitative MRI and faster brain scans via synthetic imaging, overlapping with Foqus's brain MRI acceleration focus and hospital radiology workflow.
  • RapidAI: RapidAI provides AI-driven imaging analysis (mainly stroke and neurovascular), serving hospital radiology and stroke networks; comparable AI imaging workflow footprint to Foqus in neuro MRI.
  • Subtle Medical: Subtle Medical builds AI-powered MRI and PET acceleration software (SubtleMR, SubtleGAD) that integrates with existing scanners. Direct overlap with DeepFoqus-Accelerate in AI reconstruction and hospital sales motion.
  • Arterys (Tempus): Arterys (now part of Tempus AI) provides cloud-native AI medical imaging platforms including MRI quantification and visualization, competing for AI imaging analytics budgets at the same hospital radiology departments.

Broad incumbents

  • GE HealthCare: GE HealthCare is a major MRI OEM whose AIR Recon DL product is an AI-based MRI reconstruction tool bundled with its scanners. Represents both a competing AI reconstruction solution and a potential integration channel for Foqus.
  • Siemens Healthineers: Siemens Healthineers offers Deep Resolve, an AI-based MRI acceleration technology integrated into its MAGNETOM scanners, making it a direct competing AI reconstruction capability and a key OEM counterpart.
  • Philips: Philips offers SmartSpeed AI MRI acceleration as part of its Ingenia and other MR platforms, providing competing vendor-bundled reconstruction and a major OEM integration target for Foqus.

Emerging players

  • Ezra: Ezra offers AI-assisted full-body MRI screening with a focus on faster, more accessible scans for early cancer detection; overlaps with Foqus on the AI-driven faster-MRI thesis but targets consumers/employers.
  • Hyperfine: Hyperfine develops portable, low-field MRI with AI-driven reconstruction, targeting point-of-care and lower-cost settings; adjacent technology (AI + MRI acceleration) and overlapping MRI access mission.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Foqus social profiles

Digital presence

Foqus compliance and trust

Trust signal

Compliance4 records

Foqus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Foqus leadership team

Management profile

Number of profiles

Profiles1 record

Foqus funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Foqus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Foqus

What does Foqus do?

Foqus Technologies develops and sells DeepFoqus-Accelerate, an AI-powered MRI reconstruction software that integrates with existing 1.5T and 3T MRI scanners without requiring hardware modifications. The software uses proprietary quantum algorithms and AI-enhanced reconstruction to accept up to 4x accelerated brain MRI scans (approximately 75% time reduction, with a target of sub-5-minute scans) while maintaining diagnostic-quality image output across 2D and 3D T1, T2, and FLAIR sequences. The product has received FDA 510(k) clearance and Health Canada Medical Device License, enabling commercial deployment to hospitals and imaging centers across North America.

Is Foqus a public or private company?

Foqus is a private company. It is classified as venture growth investor backed and is currently operating.

When was Foqus founded?

Foqus was founded in 2021. It employs 1 to 10 people.

Where is Foqus based?

Foqus is headquartered in Toronto, Canada, in the North America region.

How does Foqus make money?

One revenue line is on record: software Licensing.

Who are Foqus's main competitors?

Direct peers on record are Quibim, SyntheticMR, RapidAI, Subtle Medical and Arterys (Tempus). Broad incumbents are GE HealthCare, Siemens Healthineers and Philips. Emerging players are Ezra and Hyperfine.

Does Foqus have an API?

No public API is recorded for Foqus.

What industry is Foqus in?

Foqus's product category is Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 3391 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals